Elevance Health Welcomes Steve Collis as New Board Director
ByAinvest
Monday, Jul 28, 2025 9:10 pm ET1min read
COR--
Collis brings a distinguished record of leadership, transformation, and operational excellence. He currently serves as Executive Chairman of the Board of Cencora (formerly AmerisourceBergen), a role he assumed in 2024 after a long tenure as President and CEO. During his 13-year tenure as CEO, Collis led Cencora through significant strategic transformation, expanding its global reach and deepening its capabilities across the pharmaceutical and healthcare supply chain [1].
Ramey Peru, Chair of the Elevance Health Board of Directors, stated, "Steve brings deep experience in healthcare operations and long-term value creation, aligning well with our strategic objectives. His insights will support our continued focus on delivering high-quality care, driving innovation, and creating enduring value for the people and communities we serve" [1].
Elevance Health, a lifetime, trusted health partner, supports consumers, families, and communities across the entire healthcare journey. The company serves over 109 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions [1].
References:
[1] https://www.elevancehealth.com/newsroom/elevance-health-board-welcomes-steve-collis-as-new-director
[2] https://www.morningstar.com/news/business-wire/20250728510661/elevance-health-board-welcomes-steve-collis-as-new-director-reflecting-ongoing-commitment-to-governance-excellence
[3] https://www.businesswire.com/news/home/20250728510661/en/Elevance-Health-Board-Welcomes-Steve-Collis-as-New-Director-Reflecting-Ongoing-Commitment-to-Governance-Excellence
ELV--
Elevance Health's board of directors welcomes Steve Collis, a global healthcare executive, as a new director, effective August 1. He will serve on the Audit and Finance Committees, enhancing the board's industry expertise and financial oversight capabilities. His addition is part of the board's ongoing commitment to governance excellence and strategy refresh.
Elevance Health (NYSE: ELV) has announced the addition of Steve Collis to its board of directors, effective August 1, 2025. Collis, a highly regarded global healthcare executive, will serve on the Audit and Finance Committees, enhancing the board's industry expertise and financial oversight capabilities. His appointment reflects the company's ongoing commitment to governance excellence and strategic refresh [1].Collis brings a distinguished record of leadership, transformation, and operational excellence. He currently serves as Executive Chairman of the Board of Cencora (formerly AmerisourceBergen), a role he assumed in 2024 after a long tenure as President and CEO. During his 13-year tenure as CEO, Collis led Cencora through significant strategic transformation, expanding its global reach and deepening its capabilities across the pharmaceutical and healthcare supply chain [1].
Ramey Peru, Chair of the Elevance Health Board of Directors, stated, "Steve brings deep experience in healthcare operations and long-term value creation, aligning well with our strategic objectives. His insights will support our continued focus on delivering high-quality care, driving innovation, and creating enduring value for the people and communities we serve" [1].
Elevance Health, a lifetime, trusted health partner, supports consumers, families, and communities across the entire healthcare journey. The company serves over 109 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions [1].
References:
[1] https://www.elevancehealth.com/newsroom/elevance-health-board-welcomes-steve-collis-as-new-director
[2] https://www.morningstar.com/news/business-wire/20250728510661/elevance-health-board-welcomes-steve-collis-as-new-director-reflecting-ongoing-commitment-to-governance-excellence
[3] https://www.businesswire.com/news/home/20250728510661/en/Elevance-Health-Board-Welcomes-Steve-Collis-as-New-Director-Reflecting-Ongoing-Commitment-to-Governance-Excellence
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet